Evaluation of Flibanserin: Science and Advocacy at the FDA

JAMA. 2015 Sep 1;314(9):869-70. doi: 10.1001/jama.2015.8405.
No abstract available

Publication types

  • Historical Article

MeSH terms

  • Advisory Committees
  • Benzimidazoles / adverse effects
  • Benzimidazoles / history*
  • Benzimidazoles / therapeutic use
  • Consumer Advocacy / history*
  • Depression / drug therapy
  • Drug Approval / history*
  • Drug Approval / methods
  • Female
  • History, 21st Century
  • Humans
  • Libido / drug effects
  • National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division
  • Sexual Dysfunctions, Psychological / drug therapy
  • Sexual Dysfunctions, Psychological / history*
  • United States
  • United States Food and Drug Administration

Substances

  • Benzimidazoles
  • flibanserin